Although CD133 was detected in a minimum percentage of OVCAR-5 cells (5.6% to 16.0%) it was recently shown that targeting a small number of CD133 positive cells can selectively decrease tumor progression of OVCAR-5-luc tumors37. This evidence concerns the gene PROM1 and neoplasm.